Anti-Ocrelizumab Polyclonal Antibody
Product Specifications
Background
Ocrelizumab (Ocrevus®) is an intravenously administered, humanized anti-CD20 monoclonal antibody approved for the treatment of adults with relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS) . Antibodysystem Anti-Ocrelizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ocrelizumab.
Host
Rabbit
Immunogen
Ocrelizumab
Target
Rabbit polyclonal to Ocrevus.
Clonality
Polyclonal
Applications
ELISA
Purification
Purified by antigen affinity column.
Form
Liquid
Buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Storage Conditions
The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.
Notes
Antibodysystem can customize this product per customer's request including product size, buffer components, etc. For research use only.
Specificity
The product is specific for Ocrelizumab. This antibody serves as an excellent positive control for Ocrelizumab immunogenicity (ADA) assays.
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SIPD116Ra01-01 10 µg
Recombinant Interleukin 17 Receptor E (IL17RE)
Sign In for Pricing
View Details SIPD116Ra01-02 50 µg
Recombinant Interleukin 17 Receptor E (IL17RE)
Sign In for Pricing
View Details